Amarin Corporation plc [AMRN] fell -17.51% so far this year. What now?


Amarin Corporation plc [NASDAQ: AMRN] stock went on a downward path that fall over -6.71% on Thursday, amounting to a one-week price decrease of less than -8.85%. The company report on April 26, 2022 that Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl).

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Amarin Corporation plc (NASDAQ:AMRN) announced today its partner HLS Therapeutics has completed negotiations with Canada’s pan-Canadian Pharmaceutical Alliance (pCPA) for the terms and conditions under which VASCEPA® (icosapent ethyl) would qualify for public market reimbursement in Canada. Following these negotiations, HLS has signed a Letter of Intent (LOI) which allows HLS to work with all participating provincial jurisdictions to secure coverage from publicly funded drug plans across Canada, and for VASCEPA to potentially be added to their respective plans.

“The completion of pCPA’s assessment regarding reimbursement represents an important milestone towards advancing the potential reach of therapies across Canada,” said Karim Mikhail, president & chief executive officer, Amarin Corporation. “We look forward to continued efforts to secure coverage across the various Canadian jurisdictions, which would significantly increase access to VASCEPA for statin-treated patients with established cardiovascular disease and elevated triglycerides across Canada.”.

Over the last 12 months, AMRN stock dropped by -46.95%. The one-year Amarin Corporation plc stock forecast points to a potential upside of 64.94. The average equity rating for AMRN stock is currently 2.30, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $1.15 billion, with 396.93 million shares outstanding and 381.31 million shares in the current float. Compared to the average trading volume of 2.76M shares, AMRN stock reached a trading volume of 4405075 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Amarin Corporation plc [AMRN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMRN shares is $7.93 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMRN stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Goldman have made an estimate for Amarin Corporation plc shares, keeping their opinion on the stock as Sell, with their previous recommendation back on May 12, 2021. While these analysts kept the previous recommendation, JP Morgan raised their target price to Neutral. The new note on the price target was released on September 29, 2020, representing the official price target for Amarin Corporation plc stock. Previously, the target price had yet another raise to $21, while Piper Sandler analysts kept a Overweight rating on AMRN stock.

The Average True Range (ATR) for Amarin Corporation plc is set at 0.15, with the Price to Sales ratio for AMRN stock in the period of the last 12 months amounting to 1.97. The Price to Book ratio for the last quarter was 1.65, with the Price to Cash per share for the same quarter was set at 1.10.

AMRN Stock Performance Analysis:

Amarin Corporation plc [AMRN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.85. With this latest performance, AMRN shares dropped by -17.75% in over the last four-week period, additionally sinking by -39.30% over the last 6 months – not to mention a drop of -46.95% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRN stock in for the last two-week period is set at 30.61, with the RSI for the last a single of trading hit 22.51, and the three-weeks RSI is set at 35.71 for Amarin Corporation plc [AMRN]. The present Moving Average for the last 50 days of trading for this stock 3.20, while it was recorded at 2.95 for the last single week of trading, and 4.03 for the last 200 days.

Insight into Amarin Corporation plc Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Amarin Corporation plc [AMRN] shares currently have an operating margin of +4.15 and a Gross Margin at +78.71. Amarin Corporation plc’s Net Margin is presently recorded at +1.33.

Return on Equity for this stock inclined to 1.19, with Return on Assets sitting at 0.76.

Amarin Corporation plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.70 and a Current Ratio set at 2.40.


The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMRN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Amarin Corporation plc go to 38.90%.

Amarin Corporation plc [AMRN] Insider Position Details

There are presently around $378 million, or 36.70% of AMRN stock, in the hands of institutional investors. The top three institutional holders of AMRN stocks are: BAKER BROS. ADVISORS LP with ownership of 21,169,805, which is approximately -3.14% of the company’s market cap and around 0.40% of the total institutional ownership; SARISSA CAPITAL MANAGEMENT LP, holding 19,250,000 shares of the stock with an approximate value of $53.52 million in AMRN stocks shares; and BVF INC/IL, currently with $45.76 million in AMRN stock with ownership of nearly 44.295% of the company’s market capitalization.

Positions in Amarin Corporation plc stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 91 institutional holders increased their position in Amarin Corporation plc [NASDAQ:AMRN] by around 26,084,036 shares. Additionally, 99 investors decreased positions by around 10,448,526 shares, while 83 investors held positions by with 99,358,468 shares. The mentioned changes placed institutional holdings at 135,891,030 shares, according to the latest SEC report filing. AMRN stock had 39 new institutional investments in for a total of 5,301,266 shares, while 38 institutional investors sold positions of 3,875,643 shares during the same period.